S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94

Synthetic Biologics Short Interest Ratio and Short Volume

0.00 (0.00 %)
(As of 10/15/2021 04:00 PM ET)
Today's Range
50-Day Range N/A
52-Week Range
Volume812,252 shs
Average Volume8.86 million shs
Market Capitalization$57.44 million
P/E RatioN/A
Dividend YieldN/A

Synthetic Biologics (NYSEAMERICAN:SYN) Short Interest Data

Current Short Volume12,200 shares
Previous Short Volume464,000 shares
Change Vs. Previous Month-97.37%
Dollar Volume Sold Short$0.00
Short Interest Ratio / Days to Cover0.0
Last Record DateSeptember, 30 2021
Outstanding Shares132,043,000 shares
Float Size129,710,000 shares
Short Percent of Float0.01%
Today's Trading Volume812,252 shares
Average Trading Volume8,856,376 shares
Today's Volume Vs. Average-90.83%

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Synthetic Biologics ?

Sign up to receive the latest short interest report for Synthetic Biologics and its competitors with MarketBeat's FREE newsletter.

Synthetic Biologics (NYSEAMERICAN:SYN) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/202112,200 shares $0.00 -97.4%0.0%0 $0.00
9/15/2021464,000 shares $0.00 +1,849.6%0.4%0.3 $0.00
8/31/202123,800 shares $0.00 +28.0%0.0%0 $0.00
8/13/202118,600 shares $0.00 -79.3%0.0%0 $0.00
7/30/202189,900 shares $0.00 -15.9%0.1%0 $0.00
7/15/2021106,900 shares $0.00 -70.3%0.1%0 $0.00
6/30/2021359,300 shares $0.00 -55.8%0.3%0.1 $0.00
6/15/2021812,100 shares $0.00 +3.8%0.6%0.2 $0.00
5/28/2021782,300 shares $0.00 +10.3%0.6%0.1 $0.00
5/14/2021709,100 shares $0.00 -38.9%N/A0.1 $0.00
4/30/20211,160,000 shares $0.00 -79.4%N/A0.1 $0.00
4/15/20215,620,000 shares $2.81 million +0.7%N/A0.4 $0.50
3/31/20215,580,000 shares $3.24 million +4.9%N/A0.3 $0.58
3/15/20215,320,000 shares $3.19 million -45.4%N/A0.2 $0.60
2/26/20219,740,000 shares $6.53 million +264.8%N/A0.5 $0.67
2/12/20212,670,000 shares $1.82 million +35.5%N/A0.2 $0.68
1/29/20211,970,000 shares $1.46 million +8.8%N/A0.2 $0.74
1/15/20211,810,000 shares $1.99 million +565.4%N/A0.2 $1.10
12/31/2020272,000 shares $113,424.00 +31.5%N/A0 $0.42
12/15/2020206,900 shares $72,934.32 -36.0%N/A0.3 $0.35
11/30/2020323,300 shares $121,172.84 +2.0%N/A0.6 $0.37
11/15/2020317,000 shares $108,572.50 +17.5%N/A0.5 $0.34
10/30/2020269,700 shares $83,660.94 +666.2%N/A0.4 $0.31
10/15/202035,200 shares $11,795.52 -75.4%N/A0 $0.34
9/30/2020143,000 shares $67,882.10 +135.2%N/A0.2 $0.47

Synthetic Biologics (NYSEAMERICAN:SYN) Short Interest FAQ

Synthetic Biologics (NYSEAMERICAN:SYN) Short Interest Frequently Asked Questions

What is Synthetic Biologics' current short interest?

Short interest is the volume of Synthetic Biologics shares that have been sold short but have not yet been covered or closed out. As of September 30th, investors have sold 12,200 shares of SYN short. 0.01% of Synthetic Biologics' shares are currently sold short. Learn More on Synthetic Biologics' current short interest.

What is a good short interest percentage for Synthetic Biologics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.01% of Synthetic Biologics' floating shares are currently sold short.

Is Synthetic Biologics' short interest increasing or decreasing?

Synthetic Biologics saw a drop in short interest in the month of September. As of September 30th, there was short interest totaling 12,200 shares, a drop of 97.4% from the previous total of 464,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Synthetic Biologics' float size?

Synthetic Biologics currently has issued a total of 132,043,000 shares. Some of Synthetic Biologics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Synthetic Biologics currently has a public float of 129,710,000 shares.

How does Synthetic Biologics' short interest compare to its competitors?

0.01% of Synthetic Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Synthetic Biologics: RedHill Biopharma Ltd. (2.84%), Immunic, Inc. (5.42%), AVEO Pharmaceuticals, Inc. (6.34%), Inozyme Pharma, Inc. (2.07%), Larimar Therapeutics, Inc. (3.07%), Immunome, Inc. (3.08%), Flora Growth Corp. (1.43%), Corvus Pharmaceuticals, Inc. (10.90%), Mustang Bio, Inc. (8.62%), and Alzamend Neuro, Inc. (0.72%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($7.35 billion), Advanced Micro Devices, Inc. ($6.43 billion), Charter Communications, Inc. ($5.68 billion), Wayfair Inc. ($4.48 billion), Uber Technologies, Inc. ($3.77 billion), Canadian Pacific Railway Limited ($3.73 billion), Palo Alto Networks, Inc. ($3.10 billion), Zoom Video Communications, Inc. ($2.87 billion), Match Group, Inc. ($2.83 billion), and DoorDash, Inc. ($2.54 billion). View all of the most shorted stocks.

What does it mean to sell short Synthetic Biologics stock?

Short selling SYN is an investing strategy that aims to generate trading profit from Synthetic Biologics as its price is falling. To short Synthetic Biologics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Synthetic Biologics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Synthetic Biologics?

A short squeeze for Synthetic Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SYN, which in turn drives the price of the stock up even further.

How often is Synthetic Biologics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SYN, twice per month. The most recent reporting period available is September, 30 2021.

This page was last updated on 10/17/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.